Drug Company Will Buy Up to $700 Million in BNB After Coin Hits All-Time High
Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on its balance sheet.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This altcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Elon Musk’s Grok AI Predicts When Bitcoin Will Finally Hit its Ultimate Price Target
X and SpaceX CEO Elon Musk’s Grok AI predicts something potentially historic could be brewing for Bitcoin by January 1, 2027. This...
Generali Group adds 100,985 shares of Bitcoin treasury company Strategy
Generali's investment in Strategy highlights a growing trend of institutions using indirect methods to gain Bitcoin exposure, impa...
Bitcoin ETFs pull in $110 million as Ether funds shed $88.58 million
Bitcoin's ETF inflows highlight its market dominance, while Ether's outflows suggest shifting investor confidence and potential vo...
Bitcoin Mining Firm Luxor Raises $16 Million to Scale Its AI Compute Push
The CMT Digital-led round, which drew mining-hardware makers Canaan and MicroBT, will fund Luxor’s expansion into AI compute tradi...
Ark Invest buys $5.2 million of Circle shares, sells $15.9 million of its own Bitcoin ETF as BTC grinds lower
Ark Invest rebalanced its fund weightings, adding Circle shares and trimming its Bitcoin ETF holdings as BTC fell below $80,000.
Now Accepting Bitcoin: 425 Los Angeles Bitcoin Merchants featuring Café de Leche
Bitcoin Magazine Now Accepting Bitcoin: 425 Los Angeles Bitcoin Merchants featuring Café de Leche The Los Angeles Bitcoin scene is...